Clinical Trials Directory

Trials / Unknown

UnknownNCT05385003

Effect of Prebiotics on Hyperuricemia

An Interventional Study for the Beneficial Effects of Prebiotics on Hyperuricemia in Chinese Subjects

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
120 (estimated)
Sponsor
Sun Yat-sen University · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

Hyperuricemia is a major risk factor for many chronic diseases. Recently, dysbiosis of gut microbiota has been reported to play an important role in the pathogenesis of Hyperuricemia. Animal studies have demonstrated that administration of prebiotics help delay the progression of Hyperuricemia through several mechanisms. This trial aims to examine its protective effect in humans.

Detailed description

Hyperuricemia is a major risk factor for many chronic diseases. Recently, dysbiosis of gut microbiota has been reported to play an important role in the pathogenesis of hyperuricemia. Animal studies have demonstrated that administration of prebiotics help delay the progression of hyperuricemia through several mechanisms such as reduction in endotoxemia, and enhanced production of short-chain fatty acids. However, whether administration of prebiotics also has a protective effect in subjects with Hyperuricemia remain unknown.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTanserineDuring the study period, subjects are instructed to take one capsule of anserine daily for a total of 3 months. Aside from the prebiotic supplement, all participants are instructed to continue their normal routine and not make any changes to their exercise habits but reduce purine intake.
DIETARY_SUPPLEMENTSunflower peptideDuring the study period, subjects are instructed to take one capsule of Sunflower peptide daily for a total of 3 months. Aside from the prebiotic supplement, all participants are instructed to continue their normal routine and not make any changes to their exercise habits but reduce purine intake.
DIETARY_SUPPLEMENTPlacebo controlDuring the study period, subjects are instructed to take one capsule of placebo control daily for a total of 3 months. Aside from the probiotic supplement, all participants are instructed to continue their normal routine and not make any changes to their exercise habits but reduce purine intake.

Timeline

Start date
2022-05-14
Primary completion
2023-08-31
Completion
2023-12-31
First posted
2022-05-23
Last updated
2022-05-23

Locations

2 sites across 1 country: China

Source: ClinicalTrials.gov record NCT05385003. Inclusion in this directory is not an endorsement.